Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 03/11/2015 1:42:04 PM
Post# of 30067
Avatar
Posted By: Warp
Re: Deputy_123 #17906
Deputy, I never said the company currently has the market cornered for blood-based AD diagnostic testing. That only happens when all 3 testing modalities are brought to market. LymPro still has to achieve CLIA certification and FDA approval, as well as approval in the EU. The two tests to be licensed will have to undergo further testing before commercialization.

It is asinine to think the company has cornered the market when 2 of the 3 tests haven't even reached the market. GC was referring to some point in the future, not the current state of things. Think before you post.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site